At IFM Therapeutics, they work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body’s first line of immunological response, and an essential component of immune function.

Biotechnology

IFM Therapeutics

H. Martin Seidel

William R. Roush

Sujen Lai, PMP

Shankar Venkatraman

Ann Santilli

Ed Olhava

Dennis Dean

The Leadership Team at IFM Therapeutics is dedicated to guiding the company’s strategic vision and fostering innovation in the development of therapies for inflammatory disorders and cancer. Comprising scientific founders and executive leaders, this team drives research initiatives, oversees clinical development, and ensures alignment with the company's mission to leverage innate immunity for transformative medicine. Their collective expertise shapes the organization’s goals and enhances its ability to deliver impactful treatments to patients.

Leadership Team

Research and Development

Scientific Research Team

Leadership Team

About

Team members

Other teams at IFM Therapeutics

Research and Development

Scientific Research Team